ReShape Lifesciences Liabilities 2024

ReShape Lifesciences Aktienanalyse

What does ReShape Lifesciences do?

ReShape Lifesciences Inc is a medical company that was founded in 2018 and is headquartered in San Clemente, California. The company is involved in the development and marketing of medical devices for the treatment of obesity and metabolic disorders. The company's business model focuses on innovative medical devices and services for the treatment of obesity and metabolic disorders. The company's main goal is to help patients improve their weight and health in a non-surgical way. The company offers not only medical devices but also services such as physician consulting, training for medical professionals, and patient support. The company's core products include the ReShape Vest, a non-invasive weight loss therapy approach, and the ReShape Duo System, a secondary gastric balloon system used in combination with a dietary program to support weight reduction. The company also offers the ReShape Care Plan, a comprehensive program for patients with obesity that is managed by a multidisciplinary team. The program includes individual sessions with a certified dietitian and a behavioral coach to motivate patients through concrete guidance for weight reduction. ReShape Lifesciences is dedicated to research and development of medical devices and services that help patients in weight reduction and improving their health. The company aims to create an affordable, safe, and effective treatment for obesity patients in an innovative manner that aligns with healthcare reform. ReShape Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing ReShape Lifesciences's Liabilities

ReShape Lifesciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating ReShape Lifesciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing ReShape Lifesciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

ReShape Lifesciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in ReShape Lifesciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about ReShape Lifesciences Stock

What is the level of liabilities of ReShape Lifesciences this year?

ReShape Lifesciences has a debt balance of 4 M USD this year.

What were the liabilities of ReShape Lifesciences compared to the previous year?

The liabilities of ReShape Lifesciences have increased by -46.52% dropped compared to the previous year.

What are the consequences of high debt for investors of ReShape Lifesciences?

High liabilities can pose a risk for investors of ReShape Lifesciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in ReShape Lifesciences?

Low liabilities mean that ReShape Lifesciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of ReShape Lifesciences affect the company?

An increase in liabilities of ReShape Lifesciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of ReShape Lifesciences affect the company?

A decrease in the liabilities of ReShape Lifesciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of ReShape Lifesciences?

Some factors that can influence the liabilities of ReShape Lifesciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of ReShape Lifesciences so important for investors?

The liabilities of ReShape Lifesciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can ReShape Lifesciences take to modify the liabilities?

To change its liabilities, ReShape Lifesciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does ReShape Lifesciences pay?

Over the past 12 months, ReShape Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ReShape Lifesciences is expected to pay a dividend of 0 USD.

What is the dividend yield of ReShape Lifesciences?

The current dividend yield of ReShape Lifesciences is .

When does ReShape Lifesciences pay dividends?

ReShape Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ReShape Lifesciences?

ReShape Lifesciences paid dividends every year for the past 0 years.

What is the dividend of ReShape Lifesciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ReShape Lifesciences located?

ReShape Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von ReShape Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ReShape Lifesciences from 5/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.

When did ReShape Lifesciences pay the last dividend?

The last dividend was paid out on 5/29/2024.

What was the dividend of ReShape Lifesciences in the year 2023?

In the year 2023, ReShape Lifesciences distributed 0 USD as dividends.

In which currency does ReShape Lifesciences pay out the dividend?

The dividends of ReShape Lifesciences are distributed in USD.